← Back to Search

EDITH-HC Training Tool for Dementia Care (EDITH-HC Trial)

N/A

Recruiting

Led By Elizabeth Luth, PhD

Research Sponsored by Rutgers, The State University of New Jersey

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months post-intervention, 6 months post-intervention

Awards & highlights

No Placebo-Only Group

Summary

This trial will test a tool to help hospice clinicians better care for people with dementia & their family caregivers, to reduce caregiver burden & improve care.

Who is the study for?

This trial is for nurses, social workers, or family members aged 19-90 who care for someone with dementia in home hospice. Participants must speak English and identify as White or Black/African American. While gender isn't a factor for exclusion, it's anticipated that most participants will be female.

What is being tested?

The study tests 'EDITH-HC', a training and tool designed to enhance dementia care by home hospice clinicians. It aims to see if this can reduce caregiver burden and increase clinicians' knowledge about dementia caregiving compared to usual care.

What are the potential side effects?

Since the intervention involves educational material rather than medical treatment, traditional side effects are not applicable. However, there may be indirect effects on stress levels or emotional state of caregivers due to changes in caregiving practices.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months post-intervention, 6 months post-intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months post-intervention, 6 months post-intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months post-intervention, 6 months post-intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Family Caregiver Burden

Secondary study objectives

Clinician knowledge of dementia-related issues at end of life

Other study objectives

Family caregiver preparedness (exploratory)

Family caregiver self-efficacy (exploratory)

Patient hospice discharge status (exploratory)

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Intervention GroupExperimental Treatment1 Intervention

Clinicians in intervention group will watch a series educational and instructional videos and use caregiver burden assessment tool up to four times during regular home visits with family caregivers of home hospice patients living with dementia. Clinicians will be assessed for changes in knowledge regarding dementia caregiving (secondary outcome). Family caregivers will be assessed for changes in caregiver burden (primary outcome) and preparedness and self-efficacy (exploratory outcomes).

Group II: Control GroupExperimental Treatment1 Intervention

Clinicians in control group will listen to a presentation on outcomes for home hospice patients living with dementia. Clinicians will be assessed for changes in knowledge regarding dementia caregiving (secondary outcome). Family caregivers will be assessed for changes in caregiver burden (primary outcome) and preparedness and self-efficacy (exploratory outcomes).

Do I qualify?Apply below to find out